MedPath

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

Not Applicable
Conditions
Healthy
Registration Number
NCT01988545
Lead Sponsor
Zealand University Hospital
Brief Summary

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters

Detailed Description

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
8
Inclusion Criteria
  • healthy subjects
Exclusion Criteria
  • medical conditions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
blood flowwith in 120 minutes

blood flow change measured by ultra sound

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Køge Hospital

🇩🇰

Køge, State..., Denmark

Køge Hospital
🇩🇰Køge, State..., Denmark
lasse bremholm, MD, ph.d.
Contact
004560927874
lassebremholm@dadlnet.dk
Lasse Bremholm, MD, ph.d.
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath